This ACE Clinical Guidance (ACG) highlights the importance of early identification of patients at increased risk of chronic kidney disease (CKD), providing evidence-based recommendations for timely detection, diagnosis, and staging of CKD.
Download the PDF below to access the ACG.
Registered doctors, pharmacists and nurses may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A/ category V-B for reading each ACG.
| ACG recommendations |
|---|
| 1. | Identify patients at increased risk of CKD by assessing their risk factors and determine the need to evaluate for CKD. |
| 2. | Diagnose CKD if any of the following is present for at least three months:- GFR < 60 mL/min/1.73m2
- UACR ≥ 3 mg/mmol (≥ 30 mg/g)
- Other marker of kidney damage
|
| 3. | Determine the stage of CKD based on GFR, UACR, and the cause(s) of CKD. |
| 4. | For patients diagnosed with CKD, discuss the diagnosis and management options with the patient. |
| 5. | For patients who do not have CKD but are at increased risk, monitor for CKD regularly. |
| 6. | Referral to a specialist could be made at any point.
|
CKD – early detection (October 2022)
CKD – early detection References (Oct 2022)
Feedback
Click here to give us feedback on this ACG.
Related ACGs